| Combination of | |
|---|---|
| Ticarcillin | β-lactam antibiotic |
| Clavulanic acid | β-lactamase inhibitor |
| Clinical data | |
| Trade names | Timentin |
|
Routes of administration | Injection |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
Ticarcillin/clavulanic acid, or co-ticarclav, is a combination antibiotic consisting of ticarcillin, a β-lactam antibiotic, and clavulanic acid, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against ticarcillin-resistant bacteria that produce certain β-lactamases. [1]
References
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |